Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis
- 1 September 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (3) , 909-918
- https://doi.org/10.1016/s0002-9440(10)64251-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Adenoviral Vector Expressing Murine Angiostatin Inhibits a Model of Breast Cancer Metastatic Growth in the Lungs of MiceThe American Journal of Pathology, 2001
- Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunityGene Therapy, 2001
- Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosisHuman Reproduction, 1999
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- Cancer risk after a hospital discharge diagnosis of endometriosisAmerican Journal of Obstetrics and Gynecology, 1997
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.Journal of Clinical Investigation, 1996
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.Proceedings of the National Academy of Sciences, 1994
- Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In VitroObstetrics & Gynecology, 1990
- Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancerJournal of Clinical Epidemiology, 1990